Canada markets open in 8 minutes

JCR Pharmaceuticals Co., Ltd. (JCRRF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
5.22-0.98 (-15.81%)
At close: 09:42AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 473.01M
Enterprise Value 504.27M
Trailing P/E 19.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.44
Price/Book (mrq)2.03
Enterprise Value/Revenue 1.88
Enterprise Value/EBITDA 10.71

Trading Information

Stock Price History

Beta (5Y Monthly) -0.01
52-Week Change 3-44.99%
S&P500 52-Week Change 324.96%
52 Week High 310.11
52 Week Low 35.22
50-Day Moving Average 35.22
200-Day Moving Average 38.04

Share Statistics

Avg Vol (3 month) 31
Avg Vol (10 day) 3N/A
Shares Outstanding 5124.8M
Implied Shares Outstanding 6124.93M
Float 873.39M
% Held by Insiders 143.26%
% Held by Institutions 115.82%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.13
Forward Annual Dividend Yield 42.47%
Trailing Annual Dividend Rate 320.00
Trailing Annual Dividend Yield 3322.58%
5 Year Average Dividend Yield 4N/A
Payout Ratio 445.54%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 27, 2024
Last Split Factor 24:1
Last Split Date 3Sept 30, 2020

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 12.85%
Operating Margin (ttm)-3.03%

Management Effectiveness

Return on Assets (ttm)4.77%
Return on Equity (ttm)10.17%

Income Statement

Revenue (ttm)42.87B
Revenue Per Share (ttm)343.54
Quarterly Revenue Growth (yoy)19.70%
Gross Profit (ttm)N/A
EBITDA 10.73B
Net Income Avi to Common (ttm)5.51B
Diluted EPS (ttm)0.27
Quarterly Earnings Growth (yoy)70.10%

Balance Sheet

Total Cash (mrq)18.76B
Total Cash Per Share (mrq)150.28
Total Debt (mrq)23.3B
Total Debt/Equity (mrq)41.26%
Current Ratio (mrq)1.91
Book Value Per Share (mrq)450.11

Cash Flow Statement

Operating Cash Flow (ttm)9.31B
Levered Free Cash Flow (ttm)4.25B